Author:
Durand M.,Boire G.,Komarova S.V.,Dixon S.J.,Sims S.M.,Harrison R.E.,Nabavi N.,Maria O.,Manolson M.F.,Mizianty M.,Kurgan L.,de Brum-Fernandes A.J.
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference33 articles.
1. Role of cytokines in rheumatoid arthritis;Feldmann;Annu Rev Immunol,1996
2. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women;Bekker;J Bone Miner Res,2004
3. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial;Cohen;Arthritis Rheum,2008
4. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis;Romas;Am J Pathol,2002
5. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis;Pettit;Am J Pathol,2001
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献